BioCentury
ARTICLE | Company News

GlaxoSmithKline, Wyeth deal

September 5, 2005 7:00 AM UTC

GSK acquired a vaccine manufacturing facility from WYE for an undisclosed amount of cash. WYE discontinued operations at the plant last year. GSK will use the Marietta, Penn., plant for secondary prod...